• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LKB1/STK11失活在肺腺癌中是常见事件。

Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.

作者信息

Sanchez-Cespedes Montserrat, Parrella Paola, Esteller Manel, Nomoto Shuji, Trink Barry, Engles James M, Westra William H, Herman James G, Sidransky David

机构信息

Department of Otolaryngology-Head and Neck Surgery, Head and Neck Cancer Research Division, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205-2196, USA.

出版信息

Cancer Res. 2002 Jul 1;62(13):3659-62.

PMID:12097271
Abstract

Frequent losses of chromosome 19p have recently been observed in sporadic lung adenocarcinomas, targeting the location of a critical tumor suppressor gene. Here we performed fine mapping of the short arm of chromosome 19 and found that the LKB1/STK11 gene mapped in the minimal-deleted region. Because germ-line mutations at LKB1/STK11 result in the Peutz-Jeghers syndrome and an increased risk of cancer, we performed a detailed genetic screen of the LKB1/STK11 gene in lung tumors. We detected a high frequency of somatic alterations (mainly nonsense mutations) in primary lung adenocarcinomas and in lung cancer cell lines. Thus, our findings demonstrate for the first time that LKB1/STK11 inactivation is a very common event and may be integrally involved in the development of sporadic lung adenocarcinoma.

摘要

最近在散发性肺腺癌中观察到19号染色体短臂频繁缺失,该区域正是一个关键肿瘤抑制基因所在位置。在此,我们对19号染色体短臂进行了精细定位,发现LKB1/STK11基因定位于最小缺失区域。由于LKB1/STK11基因的种系突变会导致黑斑息肉综合征并增加患癌风险,我们对肺肿瘤中的LKB1/STK11基因进行了详细的遗传学筛查。我们在原发性肺腺癌和肺癌细胞系中检测到高频的体细胞改变(主要为无义突变)。因此,我们的研究结果首次证明LKB1/STK11失活是一个非常常见的事件,可能在散发性肺腺癌的发生发展中起着不可或缺的作用。

相似文献

1
Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.LKB1/STK11失活在肺腺癌中是常见事件。
Cancer Res. 2002 Jul 1;62(13):3659-62.
2
BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer.BRG1与LKB1:位于19号染色体上的两个肿瘤抑制基因与肺癌的故事
Carcinogenesis. 2009 Apr;30(4):547-54. doi: 10.1093/carcin/bgp035. Epub 2009 Jan 28.
3
Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene.用于LKB1/STK11肿瘤抑制基因的新型天然敲除肺癌细胞系。
Oncogene. 2004 May 13;23(22):4037-40. doi: 10.1038/sj.onc.1207502.
4
Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutations.携带LKB1突变的人肺腺癌的独特基因表达。
Oncogene. 2004 Jun 24;23(29):5084-91. doi: 10.1038/sj.onc.1207665.
5
Allele loss and mutation screen at the Peutz-Jeghers (LKB1) locus (19p13.3) in sporadic ovarian tumours.散发性卵巢肿瘤中Peutz-Jeghers(LKB1)基因座(19p13.3)的等位基因缺失和突变筛查。
Br J Cancer. 1999 Apr;80(1-2):70-2. doi: 10.1038/sj.bjc.6690323.
6
Low frequency of somatic mutations in the LKB1/Peutz-Jeghers syndrome gene in sporadic breast cancer.散发性乳腺癌中LKB1/黑斑息肉综合征基因的体细胞突变频率较低。
Cancer Res. 1998 Apr 1;58(7):1384-6.
7
Somatic mutations in the STK11/LKB1 gene are uncommon in rare gynecological tumor types associated with Peutz-Jegher's syndrome.STK11/LKB1基因的体细胞突变在与黑斑息肉综合征相关的罕见妇科肿瘤类型中并不常见。
Am J Pathol. 2000 Jan;156(1):339-45. doi: 10.1016/S0002-9440(10)64735-9.
8
Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma.恶性黑色素瘤中Peutz-Jeghers综合征基因LKB1/STK11的体细胞突变
Oncogene. 1999 Mar 4;18(9):1777-80. doi: 10.1038/sj.onc.1202486.
9
STK11 mutations in Peutz-Jeghers syndrome and sporadic colon cancer.黑斑息肉综合征和散发性结肠癌中的STK11突变。
Cancer Res. 1998 Nov 1;58(21):4799-801.
10
LKB1 mutation in large cell carcinoma of the lung.肺大细胞癌中的LKB1突变
Lung Cancer. 2006 Sep;53(3):285-94. doi: 10.1016/j.lungcan.2006.05.018. Epub 2006 Jul 5.

引用本文的文献

1
Targeting LKB1/STK11-mutant cancer: distinct metabolism, microenvironment, and therapeutic resistance.靶向LKB1/STK11突变型癌症:独特的代谢、微环境和治疗抗性。
Trends Pharmacol Sci. 2025 Aug;46(8):722-737. doi: 10.1016/j.tips.2025.06.008. Epub 2025 Jul 22.
2
Procyanidin B2-induced LKB1-AMPK activation mitigates vascular smooth muscle cell proliferation through inhibition of mTOR signaling.原花青素B2诱导的LKB1-AMPK激活通过抑制mTOR信号传导减轻血管平滑肌细胞增殖。
Korean J Physiol Pharmacol. 2025 Sep 1;29(5):659-667. doi: 10.4196/kjpp.25.108. Epub 2025 Jul 24.
3
Tumour- and Non-Tumour-Associated Factors That Modulate Response to PD-1/PD-L1 Inhibitors in Non-Small Cell Lung Cancer.
调节非小细胞肺癌对PD-1/PD-L1抑制剂反应的肿瘤和非肿瘤相关因素
Cancers (Basel). 2025 Jun 30;17(13):2199. doi: 10.3390/cancers17132199.
4
IL-17 links the tumor suppressor LKB1 to gastrointestinal inflammation and polyposis.白细胞介素-17将肿瘤抑制因子LKB1与胃肠道炎症及息肉病联系起来。
Sci Adv. 2025 Jun 20;11(25):eadt5933. doi: 10.1126/sciadv.adt5933.
5
Liver kinase B1 expression is associated with improved prognosis and tumor immune microenvironment features in small cell lung cancer.肝激酶B1表达与小细胞肺癌预后改善及肿瘤免疫微环境特征相关。
Front Oncol. 2025 Apr 4;15:1552506. doi: 10.3389/fonc.2025.1552506. eCollection 2025.
6
Rethinking AMPK: A Reversible Switch Fortifying Cancer Cell Stress-Resilience.重新审视AMPK:强化癌细胞应激恢复力的可逆开关
Yale J Biol Med. 2025 Mar 31;98(1):33-52. doi: 10.59249/JKBB6336. eCollection 2025 Mar.
7
PARylation-mediated post-transcriptional modifications in cancer immunity and immunotherapy.聚(ADP-核糖)化介导的癌症免疫和免疫治疗中的转录后修饰
Front Immunol. 2025 Mar 11;16:1537615. doi: 10.3389/fimmu.2025.1537615. eCollection 2025.
8
A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancer.一项关于mTORC1/2抑制在STK11缺陷型非小细胞肺癌中的II期试验。
NPJ Precis Oncol. 2025 Mar 11;9(1):67. doi: 10.1038/s41698-025-00838-4.
9
Optimizing immunotherapy for lung cancer: integrating genetic alterations and the tumor mutational burden to refine patient selection.优化肺癌免疫治疗:整合基因改变与肿瘤突变负荷以优化患者选择。
Transl Cancer Res. 2025 Jan 31;14(1):29-32. doi: 10.21037/tcr-24-1734. Epub 2025 Jan 22.
10
A CRISPR-edited isoform of the AMPK kinase LKB1 improves the response to cisplatin in A549 lung cancer cells.AMPK激酶LKB1的一种经CRISPR编辑的同工型可改善A549肺癌细胞对顺铂的反应。
J Biol Chem. 2025 Mar;301(3):108308. doi: 10.1016/j.jbc.2025.108308. Epub 2025 Feb 13.